Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Phase 1 Unknown
100 enrolled
OUTREACH
Phase 1 Unknown
75 enrolled
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Phase 1 Unknown
18 enrolled
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
96 enrolled
Phase I of XKH002 Injection in Patients
Phase 1 Unknown
110 enrolled
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Phase 1/2 Unknown
52 enrolled
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
260 enrolled
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Phase 2 Unknown
10 enrolled
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Phase 2 Unknown
30 enrolled
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
Phase 1 Unknown
9 enrolled
AMT-562 in Patients With Selected Advanced Solid Tumors
Phase 1 Unknown
72 enrolled
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
Phase 1 Unknown
12 enrolled
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
24 enrolled
Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone
Phase NA Unknown
64 enrolled
A Study of HY-0102 in Patients With Advanced Solid Tumors
Phase 1 Unknown
50 enrolled
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Phase 1 Unknown
24 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
Phase 1/2 Unknown
40 enrolled
U87 CART in Treatment of Advanced Solid Tumor
Phase 1 Unknown
12 enrolled
A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Phase 1 Unknown
42 enrolled
A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
20 enrolled
A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma
Phase 1 Unknown
11 enrolled
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Phase 1/2 Unknown
54 enrolled
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Phase 1 Unknown
72 enrolled
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
Phase 1 Unknown
78 enrolled
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Phase 1 Unknown
71 enrolled
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
Phase 1 Unknown
12 enrolled
Clinical Utility for Ion Endoluminal System
Phase NA Unknown
365 enrolled
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
Phase NA Unknown
130 enrolled
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
Phase 1 Unknown
25 enrolled
The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)
Phase NA Unknown
68 enrolled
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
Phase 3 Unknown
266 enrolled
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Phase 1 Unknown
50 enrolled
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
Phase 1 Unknown
140 enrolled
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Phase 1/2 Unknown
110 enrolled
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Phase 1 Unknown
12 enrolled
A Clinical Study of MIL93 in Solid Tumors.
Phase 1 Unknown
228 enrolled
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Phase 1 Unknown
9 enrolled
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy
Phase 1 Unknown
15 enrolled
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
Phase 1 Unknown
210 enrolled
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
Phase 1/2 Unknown
121 enrolled
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
Phase 1 Unknown
68 enrolled
MK-3475-E90
Phase 1 Unknown
54 enrolled
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Phase 1 Unknown
92 enrolled
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
Phase 1 Unknown
90 enrolled
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
Phase 1 Unknown
48 enrolled
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
Phase 1/2 Unknown
36 enrolled
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Phase 1 Unknown
30 enrolled
A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
Phase 1/2 Unknown
110 enrolled